Metacognition in Semantic Dementia: Comparison With Alzheimer's Disease
NCT ID: NCT04597827
Last Updated: 2023-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2020-10-16
2022-04-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home-based Cognitive Monitoring in MCI
NCT04350801
Mindful Awareness Program for the Prevention of Dementia: A Randomized Controlled Trial
NCT02286791
Cohort Study on Cognitive Decline in Elderly
NCT07093892
Effects of Multidomain Intervention on Cognitive Function in Community-dwelling Elderly
NCT06180161
Cognitive Changes in Mild Cognitive Impairment
NCT05821400
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Semantic dementia
Diagnosis of semantic dementia (revised criteria Moreaud et al., 2008; based on Neary et al., 1998)
Metacognition tests
Test on episodic or semantic memory
Alzheimer's disease
NIAAA 2011 criteria
Metacognition tests
Test on episodic or semantic memory
Control
MMSE above 27, no neurological or psychiatric disorder
Metacognition tests
Test on episodic or semantic memory
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Metacognition tests
Test on episodic or semantic memory
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal or corrected-to-normal vision
* for patients ONLY : doctor-approved diagnosis of semantic dementia or Alzheimer's disease
* for healthy participants ONLY: score above 27 on the MMSE
* non-opposition in participation
Exclusion Criteria
* drug or alcohol abuse
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier MOREAUD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Grenoble
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Angers
Angers, , France
CHU Bordeaux
Bordeaux, , France
Hôpital Neurologique de Lyon
Bron, , France
Hôpitaux Civils Colmar
Colmar, , France
Chu Grenoble Alpes
Grenoble, , France
CHU Rennes
Rennes, , France
CHU Vaudois
Lausanne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A02236-33
Identifier Type: OTHER
Identifier Source: secondary_id
38RC20.282
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.